BIO Statement on FDA and NIH Workforce Authorities Modernization Act
Washington, D.C. (March 17, 2016) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement regarding the introduction today by Senators Alexander and Murray of the FDA and NIH Workforce Authorities Modernization Act:
“This legislation would enhance the FDA’s ability to recruit, hire and retain world-class scientific and technical experts by providing it with common sense hiring authorities and tools. Improvements in human resources management and capability are essential if the FDA is to ensure that safe and effective new medicines, which are being developed with increasingly complex science, reach patients as efficiently and quickly as possible. We thank Senators Alexander and Murray for their leadership on this issue and for introducing this important legislation.”
Upcoming BIO Events
|
BIO International Convention |
|
|
13th Annual BIO Asia International Conference |
BIO-Europe Spring |
###
About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.